Core Laboratories Depreciation & Amortization Growth & History (CLB)
Core Laboratories's depreciation and amortization was $14.6M for fiscal 2025.
View full Core Laboratories company overviewCore Laboratories annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.6M | −$304,000 | −2.03% |
| 2024 | 2024-12-31 | $15.0M | −$831,000 | −5.26% |
| 2023 | 2023-12-31 | $15.8M | −$1.4M | −8.02% |
| 2022 | 2022-12-31 | $17.2M | −$1.4M | −7.32% |
| 2021 | 2021-12-31 | $18.5M | — | — |
Core Laboratories quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.8M | $155,000 | +4.22% |
| Q1 2026 | 2026-03-31 | $3.8M | $47,000 | +1.26% |
| Q4 2025 | 2025-12-31 | $3.7M | — | — |
| Q3 2025 | 2025-09-30 | $3.6M | −$82,000 | −2.23% |
| Q2 2025 | 2025-06-30 | $3.7M | −$100,000 | −2.65% |
| Q1 2025 | 2025-03-31 | $3.7M | −$126,000 | −3.28% |
| Q3 2024 | 2024-09-30 | $3.7M | −$253,000 | −6.44% |
| Q2 2024 | 2024-06-30 | $3.8M | −$167,000 | −4.24% |
| Q1 2024 | 2024-03-31 | $3.8M | −$201,000 | −4.97% |
| Q3 2023 | 2023-09-30 | $3.9M | −$242,000 | −5.80% |
| Q2 2023 | 2023-06-30 | $3.9M | −$423,000 | −9.70% |
| Q1 2023 | 2023-03-31 | $4.0M | — | — |
| Q3 2022 | 2022-09-30 | $4.2M | — | — |
| Q2 2022 | 2022-06-30 | $4.4M | — | — |
Core Laboratories depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Core Laboratories's depreciation and amortization decreased from $18.5M to $14.6M, a change of −$3.9M. The latest reported quarter, Q2 2026, shows $3.8M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Laboratories source filings ↗